BioStem Technologies, Inc. (BSEM) News & EventsBSEMBioStem Technologies, Inc.

Selling Stockholders Plan to Sell 2.22M Shares of Common Stock

This filing relates to the offer and sale from time to time by the selling stockholders of up to 2.22M shares of common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.

Company Not Selling 2.22M Shares of Common Stock

This filing relates to the offer and sale from time to time by the selling stockholders of up to 2.22M shares of common stock. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.

BioStem Technologies Issues 735,296 Shares at $4.08 Each

BioStem Technologies announced that it has entered into definitive agreements for the issuance and sale of 735,296 shares of the company's common stock, Series A warrants to purchase up to an aggregate of 735,296 shares of common stock and Series B warrants to purchase up to an aggregate of 735,296 shares of common stock, at a purchase price of $4.08 per share and associated warrants in a private placement priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $3.83 per share and will be exercisable immediately upon issuance. The Series A warrants will expire five years after the effective date of the Resale Registration Statement and the Series B warrants will expire twenty-four months after the effective date of the Resale Registration Statement. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.